.png){kind=icon}
PHIPA marketing rules Canada clinics must follow aren't optional guardrails; they're active enforcement territory. The Information and Privacy Commissioner of Ontario has already issued Administrative Monetary Penalties in 2025 and 2026, and federal reform is moving. Clinics that treat privacy compliance as a back-office concern are quietly eroding both their legal standing and their search rankings.
Not sure whether your forms, CRM and ad tracking would survive an IPC look? A free practice growth audit reviews the consent, data-residency and tracking setup alongside your search visibility, so you get one list of gaps rather than two.
Key Takeaways
- The IPC can impose penalties of up to $500,000 on organizations that violate PHIPA, with real penalties already issued in 2025 and 2026.
- PHIPA (Ontario) and PIPEDA (federal) are separate frameworks; neither maps onto US HIPAA.
- Section 33 of PHIPA requires express consent before any personal health information is used for marketing.
- Bill C-36, introduced in June 2026, signals further federal reform that will affect how Canadian clinics manage patient data in their marketing infrastructure.
- Privacy law is one of three rulebooks: your regulatory College governs what your advertising may say, and CASL governs every marketing email and text your clinic sends.
What Are the PHIPA Marketing Rules for Clinics?
Under Section 33 of Ontario's PHIPA, a clinic may not collect, use or disclose personal health information to market anything without the patient's express consent. In practice that means an unticked opt-in on every marketing form, a plain-language statement of what the data is for, a record of each consent, and safeguards on wherever that data is stored.
Implied consent — the kind that lets a clinic share information inside the circle of care — does not carry over to marketing. That single distinction is behind three of the four mistakes below.
What Does Digital Marketing Compliance Look Like for a Canadian Clinic?
Canadian clinic marketing sits under three rulebooks at once: privacy law (PIPEDA, plus PHIPA in Ontario and provincial equivalents) for patient data; the regulatory College that licenses your practitioners, for advertising and claims; and CASL, for any commercial email or text. Quebec adds Law 25 privacy obligations and French-language requirements on top.
This page goes deep on the first rulebook, because privacy is where the penalties are and where US-trained agencies most often get Canada wrong. The College layer — testimonials, outcome claims, “before and after” content, and how those rules differ by province — is covered in our compliance-ready guide for multi-location clinics in Canada, and our SEO, AEO and GEO services in Canada page sets out how we build all three layers into a clinic's growth work from the start.
Why Canadian Clinic Marketing Carries Real Legal Risk in 2026
The IPC issued its first Administrative Monetary Penalty under PHIPA in late 2025. It issued a second in April 2026 for unauthorized access to 436 patient records. As of early 2026, organizations face penalties of up to $500,000, and individuals up to $50,000, for contraventions of PHIPA.
On the federal side, Bill C-36, introduced in June 2026 and the government's third major attempt in six years to reform PIPEDA, would replace the existing framework with a new Digital Safety and Data Protection Commission. Clinics building marketing systems today need to account for that shift.
Google compounds the pressure. Healthcare content is classified as "Your Money or Your Life" material, meaning trust signals, accuracy, and data handling practices all feed into how your pages rank. A privacy misstep doesn't just create legal exposure. It costs you patient acquisition.
Mistake 1: Applying HIPAA Logic to Canadian Privacy Law
Many US-based agencies import HIPAA-shaped compliance policies and apply them to Canadian clinic websites. The problem is that HIPAA and Canadian privacy law aren't the same thing, and the gap creates real exposure.
PIPEDA applies to private-sector organizations across Canada that collect, use, or disclose personal information in the course of a commercial activity. Provincial laws like PHIPA are deemed "substantially similar" to PIPEDA, so Ontario clinics operate under PHIPA for health data, while PIPEDA governs inter-provincial transfers and commercial activities not covered provincially. The federal position is set out plainly on the Privacy Commissioner's PIPEDA overview, which is the right starting point for any clinic outside Ontario.
A US agency that doesn't understand this layered structure will write a privacy policy that looks compliant but isn't. That weakens trust signals on your lead capture pages and leaves you exposed to the regulators that actually have jurisdiction over your Ontario patients.
Mistake 2: Skipping Express Consent on Marketing Forms
Under Section 33 of PHIPA, health information custodians must obtain express consent from individuals before collecting, using, or disclosing personal health information for marketing purposes. Implied consent, the kind that covers treatment within the circle of care, doesn't extend to digital marketing or lead generation. Standard contact forms with no explicit opt-in checkbox create a direct compliance gap. Pre-ticked boxes don't satisfy the express consent standard either. The section itself is short and worth reading in the Personal Health Information Protection Act on Ontario e-Laws; it is the clause a regulator will quote back to you.
Best practice means building separate consent fields into every lead capture form, writing a plain-language statement that tells the patient exactly what their data will be used for, and keeping those consent records. This protects the clinic and also improves conversion quality. A patient who actively opts in is a more qualified consult than one who didn't realize they were signing up for anything. For clinics running paid patient acquisition campaigns on Google or Meta, the consent architecture needs to be in place before traffic hits the landing page.
Want your intake and lead forms checked against Section 33 before the next campaign goes live? Send us the form URLs; consent architecture is part of every audit we run for Canadian clinics.
Mistake 3: Storing Patient Data in Non-Compliant Marketing Tools
Storing personal health information in standard, non-compliant email marketing platforms or CRMs without proper safeguards is a violation of PHIPA. That includes routing Ontario patient data through US-based cloud infrastructure without appropriate data protection agreements.
Data residency matters here. Marketing data tied to Ontario patients should sit on Canadian servers. This isn't a technical preference; it's a compliance requirement that affects which CRM and automation tools your clinic can legally use.
The April 2026 IPC penalty highlights the stakes. A $2,000 penalty was issued for unauthorized access to 436 patient records. The dollar amount was relatively modest, but the formal record and reputational exposure are not. And as enforcement matures, penalties will scale with breach size. Organizations face potential AMPs of up to $500,000 as of early 2026.
If your healthcare CRM and booking automation runs through tools built for general e-commerce, not Canadian health data, that's a gap worth closing before the next IPC cycle. It is also the reason our booking and follow-up automation is configured per market — the reminder sequences, database reactivation and lead routing that work for a US clinic are re-built on compliant infrastructure with consent gates for Canadian practices, rather than copied across.
Mistake 4: Neglecting Technical Safeguards on Patient-Facing Pages
SSL/TLS encryption across every patient-facing page is a baseline, not a differentiator. Any form that collects personal information, appointment requests, health intake, contact forms, needs end-to-end encryption. A page without it fails both privacy law and Google's trust signals simultaneously.
Backend access controls matter too. The IPC has already penalized unauthorized access to patient records. Audit logs that track who accessed what, and when, are the kind of infrastructure that both demonstrates compliance and limits your exposure if a breach occurs.
On the SEO side, aggressive tactics like review-gating or broad retargeting can conflict with College advertising guidelines and data minimization principles. Healthcare web development that's built with these constraints in mind from the start avoids costly retrofits later.
Analytics and cookies also fall into scope. If your website analytics setup is sending patient behavior data to US-based servers without disclosure, that's a website compliance issue worth auditing now.
If your site was built by a generalist developer or a US agency, assume the tracking and hosting were not designed for PHIPA. A technical audit shows you where data is actually flowing before a regulator does.
What a Compliant Clinic Growth Strategy Actually Looks Like
PHIPA marketing rules Canada clinics operate under aren't a barrier to patient acquisition. They're a framework for building it properly.
Consent architecture, data residency, and tool selection should be decided before campaigns launch, not after the first lead comes in. Patient acquisition through Google and Meta can be done compliantly when data minimization principles guide how audience lists are built and what gets uploaded to ad platforms.
With Bill C-36 in progress as of June 2026, clinics that build compliance into their marketing infrastructure now will absorb federal rule changes with far less disruption than those who don't. That's a real competitive advantage in the current environment, where most practices are still treating privacy as a legal department problem.
If you want to know where your current setup has gaps, book a free practice growth audit. It covers both the compliance architecture and the SEO opportunities your clinic may be leaving on the table.
Frequently Asked Questions
Does PHIPA apply to clinics outside Ontario, or is there an equivalent in other provinces?
PHIPA itself applies only to Ontario custodians. Every other province has its own regime — Alberta's Health Information Act, British Columbia's PIPA, and health-specific statutes in New Brunswick, Newfoundland and Labrador and Nova Scotia that, like PHIPA, are deemed substantially similar to PIPEDA — and the express consent principle for marketing purposes applies consistently across all of them.
Can a clinic use patient testimonials in marketing without triggering PHIPA consent requirements?
Yes, but written express consent is required before publishing any testimonial that could identify a patient or reveal health information. A general release form isn't sufficient; the consent must specifically describe the marketing use, the platform, and what information will be disclosed.
If a breach happens, how quickly must an Ontario clinic notify the IPC?
PHIPA requires a custodian to notify affected individuals at the first reasonable opportunity, and to report to the IPC when the breach falls within the circumstances set out in the regulation (Ontario Regulation 329/04), with an annual statistical report of all privacy breaches on top. There is no fixed hour-count of the kind GDPR uses, so confirm the reporting triggers for your situation with a healthcare privacy lawyer. What the IPC enforcement record does show is that unauthorized access to even a small number of records, like 436, results in a formal penalty and public record.
Will Bill C-36 change the consent requirements clinics already follow under PHIPA?
Bill C-36 targets federal PIPEDA reform, not provincial health privacy laws, so PHIPA's Section 33 express consent requirements remain in force regardless of federal legislative outcomes. Clinics may face additional federal obligations on top of existing provincial ones if Bill C-36 passes.
Does CASL apply to a clinic's appointment reminders and email newsletters?
CASL applies to any commercial electronic message — newsletters, promotions, recall campaigns with a promotional element — so those need consent, sender identification and a working unsubscribe. Purely transactional messages such as an appointment confirmation for a booking the patient made are generally outside CASL's consent requirement, but the moment a reminder carries an offer or a service promotion it is commercial. The safe pattern is to keep transactional and marketing messages on separate consent tracks.
Can a Canadian clinic run remarketing or upload patient lists to Google and Meta?
Uploading a patient list to an ad platform is a disclosure of personal health information for marketing, which needs express consent under PHIPA and its provincial equivalents, and most clinics do not hold consent that specific. Remarketing to visitors of condition-specific pages carries the same problem on the privacy side and a data-minimization problem on top. Build audiences from anonymous, non-health signals, keep condition terms out of URLs that fire pixels, and treat list uploads as off the table unless a lawyer has reviewed the consent wording.
Do PHIPA rules apply to a US marketing agency running my clinic's campaigns?
Yes. An agency that handles personal health information on a custodian's behalf is an agent under PHIPA and may only use the information as the custodian permits and the Act allows; the clinic remains responsible for what the agent does. That is why a written agreement covering permitted uses, data residency, breach notification and return or deletion of data belongs in every agency contract — and why an agency working from a HIPAA template rather than PHIPA is a risk you carry, not them.